No abstract available
MeSH terms
-
Antineoplastic Agents / therapeutic use*
-
Clinical Trials as Topic
-
Drug Resistance, Neoplasm
-
Humans
-
Leukemia, Promyelocytic, Acute / blood
-
Leukemia, Promyelocytic, Acute / drug therapy*
-
Leukemia, Promyelocytic, Acute / genetics
-
Neoplasm Proteins / genetics
-
Nuclear Proteins*
-
Oncogene Proteins, Fusion / genetics
-
Promyelocytic Leukemia Protein
-
Transcription Factors / genetics
-
Transcription Factors / immunology
-
Translocation, Genetic
-
Tretinoin / therapeutic use*
-
Tumor Suppressor Proteins
Substances
-
Antineoplastic Agents
-
Neoplasm Proteins
-
Nuclear Proteins
-
Oncogene Proteins, Fusion
-
Promyelocytic Leukemia Protein
-
Transcription Factors
-
Tumor Suppressor Proteins
-
promyelocytic leukemia-retinoic acid receptor alpha fusion oncoprotein
-
PML protein, human
-
Tretinoin